Products/Services Used | Details | Operation |
---|---|---|
Recombinant Proteins> | Antibodies obtained from commercial sources were as following: β-actin and Histone H3 from Genscript, Ku86 (C-20) and p53 (DO-1) from Santa Cruz Biotechnology, 53BP1 (Ab172580) and NBS1 (Ab175800) from Abcam, pSer139-H2AX (clone: JWB301), BRCA1 (clone MS110) from Merck-Millipore, pSer345-CHK1 and PHF2 from Cell Signalling, PHF2 and pSer4/8-RPA2 from Bethyl, RPA2 from Novus Biologicals, Rad51 by Invitrogen and CtIP from Active Motif. | Get A Quote |
Post-translational histone modifications and chromatin remodelling play a critical role in the mechanisms controlling the integrity of the genome. Here we identify histone lysine demethylase PHF2 as a novel regulator of the DNA damage response by regulating the balance between DNA damage-induced focus formation by 53BP1 and BRCA1, critical factors in the pathway choice for DNA double strand break repair. PHF2 knock down leads to impaired BRCA1 focus formation and delays the resolution of 53BP1 foci. Moreover, irradiation-induced RPA phosphorylation and focus formation, as well as localization of CtIP, required for DNA end resection, to sites of DNA lesions are affected by depletion of PHF2. These results are in... More